Investor News

Recent articles for private investors with a focus on dividend announcements

DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
* Royal Dutch Shell's third quarter 2013 earnings, on a current cost of supplies (CCS) basis (see Note 1), were $4.2 billion compared with $6.2 billion in the same quarter a year ago. * Third quarter 2013 CCS earnings excluding identified items (see page 5) were $4.5 billion compared with $6.6 billion in the third quarter of 2012. * Compared with the third quarter 2012, CCS earnings excluding identified items were impacted by significantly weaker industry refining conditions, increased Upstream operating expenses and exploration expenses, as well as production volume impacts from maintenance and asset replacement activities. Earnings also reflected the impact of the challenging operating environment in Nigeria and lower dividends from an LNG venture. This was partly offset by higher contributions from Chemicals and increased underlying Upstream production volumes, led by Integrated Gas. * Basic CCS earnings per share excluding identified items decreased by 32% versus the third quarter 2012. * Cash flow from operating activities for the third quarter 2013 was $10.4 billion, compared with $9.5 billion in the same quarter last year. Excluding working capital movements, cash flow from operating activities for the third quarter 2013 was $9.9 billion, compared with $11.7 billion in the third quarter 2012. * Capital investment for the third quarter 2013 was $9.7 billion. Net capital investment (see Note 1) for the quarter was $9.4 billion. * Total dividends distributed in the quarter were $2.8 billion, of which $1.2 billion were settled under the Scrip Dividend Programme. During the third quarter some 45.5 million shares were bought back for cancellation for a consideration of $1.5 billion. * Gearing at the end of the third quarter 2013 was 11.2%. * A third quarter 2013 dividend has been announced of $0.45 per ordinary share and $0.90 per American Depositary Share ("ADS"), an increase of 5% compared with the third quarter 2012.
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
Summary ■ Broadly-based sales growth with Group turnover +1% CER:   - Pharmaceuticals and Vaccines sales flat: US +2%, Europe +5%, Japan +2% offset by EMAP -9%, impacted by decline in China sales and Vaccines phasing   - Consumer Healthcare +4%   - Total Group turnover ex-divestments +1%     ■ Further significant pipeline approvals and filings:   - 4 approvals; US: Tivicay for HIV and FluLaval Q-IV vaccine for flu; Europe: Tafinlar for metastatic melanoma; Japan: Relvar Ellipta for asthma   - Positive FDA Adcom recommendation for Anoro Ellipta in COPD and positive CHMP opinion for Relvar Ellipta in asthma & COPD   - 3 FDA filings: Arzerra for first-line CLL; dolutegravir-Trii for HIV; fluticasone furoate monotherapy for asthma     ■ Continued delivery of operating and financial efficiencies, strong cash generation and returns to shareholders:   - Net cash inflow from operating activities of £2.1 billion; core tax rate 23.5%   - Core EPS 28.9p (+16%) benefiting from operating, financial and long-term cost efficiencies   - Q3 dividend: 19p (+6%)   - £1 billion of shares repurchased by the end of Q3; continue to target £1-2 billion for the year       ■ Successful implementation of measures to drive strategic focus and improve growth outlook:   - Agreement to divest Lucozade and Ribena to Suntory for £1.35 billion and Arixtra/Fraxiparine and related manufacturing site to Aspen for £700 million     ■ Full year 2013 guidance reaffirmed:   - Core EPS growth of 3-4% on sales growth of around 1% (both CER)
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
FIRST HALF HIGHLIGHTS- Group H1 sales per day up 0.9% versus prior year. Sales excluding Raspberry Pi declined 1.4% as overall market conditions remain subdued.- Excluding Raspberry Pi, year on year sales growth was stable through the period in our main MDD business as Continental Europe, Asia Pacific and Emerging Markets offset weakness in North America and the UK.- Year on year sales growth trajectory in MDD Other and Industrial Products divisions slowed, primarily due to strong comparators last year.- Activity levels across the period reflected normal seasonality.- Operating margin improved through the period to 9.5% from adjusted Q4 levels of 9.2% reflecting initiatives to optimise business performance towards our targeted range.- Gross margin of 37.7% was down 0.3 percentage points from the fourth quarter but stabilised through the period.- Operating margin improvement came from management of costs and the benefit of the strategic efficiency actions taken at the end of the prior year.- The Group has made further progress with key initiatives that underpin the three pillars of our strategy.- Active customer base grew 2.7% (excluding benefit of Raspberry Pi).- New web platform implemented in Canada with roll-out across North America underway.- Investment in inventory continued in line with plans.- Sales of development tools and kits which are critical to early stages of design grew 42.0% year on year.- element14 Community now has 200,000 registered users globally.- Cash performance reflected our planned investment in inventory to further support customers' requirements as well as investments in Raspberry Pi and inventory for Akron Brass following a major contract win in India.- The Board has approved an interim dividend of 4.4p per share (2012/13: 4.4p).Commenting on the results, Laurence Bain, Chief Executive Officer, said:"Our core business has delivered a stable performance overall despite the mixed conditions that have impacted some developed markets such as North America and the UK. Focus on optimising performance saw the Group's industry leading operating margin improve from the levels experienced at the end of the prior year, making progress towards our targeted range.Our customer-centric strategy has attracted more customers to our business and provides the Group with greater opportunity as market conditions improve. Progress in the Emerging Markets, where sales growth outpaced our target, exemplifies this approach. We continue to enrich our customer proposition through investments in inventory and our new web platform, making good progress through the first half this year in the execution of these plans which are driving record levels of customer satisfaction and service performance. We remain confident in our ability to implement our strategic vision.Looking ahead to the second half, we continue to have limited forward order visibility and current market conditions remain variable.However, with our proposition benefitting from the first half inventory investments and initiatives taken to optimise business performance, we expect to continue to grow our active customer base, gain market share and drive financial performance."
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited
DividendMax Limited